Funder
National Cancer Institute
Genentech
US Cancer Pain Relief Committee
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Magge RS, DeAngelis LM (2015) The double-edged sword: neurotoxicity of chemotherapy. Blood Rev 29(2):93–100.
https://doi.org/10.1016/j.blre.2014.09.012
2. Schneider BP, Hershman DL, Loprinzi C (2015) Symptoms: chemotherapy-induced peripheral neuropathy. Adv Exp Med Biol 862:77–87.
https://doi.org/10.1007/978-3-319-16366-6_6
3. Mendoza TR, Wang XS, Williams LA, Shi Q, Vichaya EG, Dougherty PM, Thomas SK, Yucel E, Bastida CC, Woodruff JF, Cleeland CS (2015) Measuring therapy-induced peripheral neuropathy: preliminary development and validation of the Treatment-Induced Neuropathy Assessment Scale. J Pain 16(10):1032–1043.
https://doi.org/10.1016/j.jpain.2015.07.002
4. US Department of Health and Human Services Food and Drug Administration (2009). Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims.
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf
. Accessed March 19, 2018
5. Calhoun EA, Welshman EE, Chang CH, Lurain JR, Fishman DA, Hunt TL, Cella D (2003) Psychometric evaluation of the functional assessment of cancer therapy/gynecologic oncology group-neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy. Int J Gynecol Cancer 13(6):741–748
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献